✦ LIBER ✦
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass
✍ Scribed by Stanton K Shernan; Jane C.K Fitch; Nancy A Nussmeier; John C Chen; Scott A Rollins; Christopher F Mojcik; Kevin J Malloy; Thomas G Todaro; Thomas Filloon; Steven W Boyce; Deepak M Gangahar; Michael Goldberg; Lawrence J Saidman; Dennis T Mangano
- Book ID
- 116259174
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 205 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0003-4975
No coin nor oath required. For personal study only.